ADIPOQ and Insulin resistance: Additionally, cadherin-13 may also modulate plasma levels of adiponectin in humans (38), low levels of which is closely linked to a major contributor to human insulin resistance (39) and which has similarly been reported to be significantly lower in horses and ponies prior to the development of clinical laminitis (40).